Kurniawan, J., Handayu, A. D., Aprilicia, G., Bahri, D. R., & Hasan, I. (2025). Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Acta Medica Indonesiana, 56(4), 451. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/2625